(19)
(11) EP 4 584 286 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23768282.8

(22) Date of filing: 08.09.2023
(51) International Patent Classification (IPC): 
C07K 14/705(2006.01)
A61P 35/00(2006.01)
A61K 38/00(2006.01)
C12N 9/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/00; C07K 2319/00; C07K 14/705; C12N 9/10; A61P 35/00
(86) International application number:
PCT/EP2023/074709
(87) International publication number:
WO 2024/052522 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 09.09.2022 EP 22194882

(71) Applicant: Deutsches Krebsforschungszentrum
69120 Heidelberg (DE)

(72) Inventors:
  • NIEHRS, Christof
    69120 Heidelberg (DE)
  • SUN, Rui
    69120 Heidelberg (DE)

(74) Representative: Altmann Stößel Dick Patentanwälte PartG mbB 
Theodor-Heuss-Anlage 2
68165 Mannheim
68165 Mannheim (DE)

   


(54) TARGETED PD-L1 DEGRADATION